Long-term prognosis in patients undergoing redo-isolated aortic valve replacement
Abstract
Aim: To evaluate clinical outcomes after redo aortic valve replacement (AVR) with sutured valves, versus valve-in-valve transcatheter aortic valve replacement (ViV-TAVR), versus sutureless valves. Methods: We identified 113 consecutive patients undergoing redo AVR with either ViV-TAVR, redo-sutured and redo-sutureless valves between August 2010 to March 2020. Heart-team made the decision whether patient should undergo redo-sutureless versus ViV-TAVR, versus redo-sutured AVR. Results: Preoperatively, redo-sutured (n = 57), ViV-TAVR (n = 31) and redo-sutureless (n = 25) patients were compared. Postoperatively, after propensity-adjustment analysis, the redo surgical aortic valve replacement group had a higher incidence of new postoperative atrial fibrillation (POAF; p = 0.04) compared with redo-sutureless group. Follow-up outcomes analysis did not show differences among groups. Conclusion: Patients undergoing redo-sutureless AVR experienced a higher incidence of POAF compared with patients undergoing redo-sutured.
Graphical abstract
Papers of special note have been highlighted as: •• of considerable interest
References
- 1. , PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597–1607 (2010).
- 2. , PARTNER 2 Investigators Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 374(17), 1609–1620 (2016).
- 3. , PARTNER 3 Investigators Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med. 380(18), 1695–1705 (2019).
- 4. Long-term outcomes of transcatheter aortic valve replacement with the lotus valve vs corevalve/evolutr: a secondary analysis of the REPRISE III randomized clinical trial. JAMA Netw. Open 5(10), e2238792 (2022).
- 5. Ministernotomy compared with right anterior minithoracotomy for aortic valve surgery. J. Thorac. Cardiovasc. Surg. 165(3), 1022–1032 (2021).
- 6. Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: a meta-analysis of comparative studies. Catheter Cardiovasc. Interv. 101(3), 639–650 (2023).
- 7. Late outcomes of valve-in-valve transcatheter aortic valve implantation versus re-replacement: meta-analysis of reconstructed time-to-event data. Int. J. Cardiol. 2370, 112–121 (2023).
- 8. Immediate and late outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in bicuspid valves: meta-analysis of reconstructed time-to-event data. J. Card. Surg. 37(10), 3300–3310 (2022).
- 9. Clinical and haemodynamic outcomes in 658 patients receiving the perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)†. Eur. J. Cardiothorac. Surg. 49(3), 978–986 (2016). •• One of the only clinical trials on sutureless valve.
- 10. Benefits and pitfalls of the perceval sutureless bioprosthesis. Front. Cardiovasc. Med. 8, 789392 (2022). •• One of the first systematic reviews that provides details on clinical outcomes of sutureless valves.
- 11. Pearls, pitfalls, and surgical indications of the Intuity TM heart valve: a rapid deployment bioprosthesis. A systematic review of the literature. J. Card. Surg. 37(12), 5411–5417 (2022).
- 12. Conduction block after rapid deployment aortic valve replacement. Ann. Thorac. Surg. S0003–4975(22), 01083–01089 (2022).
- 13. Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur. J. Cardiothorac. Surg. 42(5), S45–S60 (2012).
- 14. Risk predictors that impact long-term prognosis in patients undergoing aortic valve replacement with the Perceval sutureless bioprosthesis. Cardiovasc. Revasc. Med. S1553–8389(23), 00129-X (2023).
- 15. Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: meta-analysis with reconstructed time-to-event data of matched studies. Catheter Cardiovasc. Interv. 99(6), 1886–1896 (2022).
- 16. Early and midterm clinical outcomes of transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement for aortic bioprosthetic valve degeneration: two faces of the same medal. J. Cardiothorac. Vasc. Anesthesia 35(11), 3223–3231 (2021).
- 17. Transcatheter aortic valve replacement programs: clinical outcomes and developments. J. Am. Heart Assoc. 9(8), e015921 (2020).
- 18. Early and long-term clinical and echocardiographic outcomes of sutureless vs. sutured bioprosthesis for aortic valve replacement. J. Cardiovasc. Dev. Dis. 10(5), 224 (2023).
- 19. Transcatheter ViV versus redo surgical AVR for the management of failed biological prosthesis: early and late outcomes in a propensity-matched cohort. JACC Cardiovasc. Interv. 13(6), 765–774 (2020).
- 20. Isolated redo aortic valve replacement versus valve-in-valve transcatheter valve replacement. Ann. Thorac. Surg. 112(2), 539–545 (2021).
- 21. Editorial: insights in heart surgery: 2022. Front. Cardiovasc. Med. 10, 1184097 (2023).
- 22. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J. Am. Coll. Cardiol. 69(3), 345–357 (2017).
- 23. . A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat. Med. 25(12), 2084–2106 (2006).
- 24. Robotic vs thoracoscopic anatomic lung resection in obese patients: a propensity-adjusted analysis. Ann. Thorac. Surg. 114(5), 1879–1885 (2022).
- 25. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur. Heart J. 39(8), 687–695 (2018).
- 26. Computed tomography assessment for transcatheter aortic valve in valve implantation: the vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J. Cardiovasc. Comput. Tomogr. 10(6), 491–499 (2016).